Skip to Main Content

Author Details

Julie M Wilson
Ontario Institute for Cancer Research
2016
35
16
PMIDPaper TitleJournal TitlePublished Year
34583947Molecular characterisation of pancreatic ductal adenocarcinoma with <i>NTRK</i> fusions and review of the literature.J Clin Pathol2023
37558751Chemokine expression predicts T cell-inflammation and improved survival with checkpoint inhibition across solid cancers.NPJ Precis Oncol2023
37449843Spectrum of Response to Platinum and PARP Inhibitors in Germline BRCA-Associated Pancreatic Cancer in the Clinical and Preclinical Setting.Cancer Discov2023
36915452Whole-genome sequencing of 20 cholangiocarcinoma cases reveals unique profiles in patients with cirrhosis and primary sclerosing cholangitis.J Gastrointest Oncol2023
36927977Systemic inflammatory prognostic scores in advanced pancreatic adenocarcinoma.Br J Cancer2023
36006427Correlation of transcriptional subtypes with a validated CT radiomics score in resectable pancreatic ductal adenocarcinoma.Eur Radiol2022
35547873Intra-Tumoral CD8+ T-Cell Infiltration and PD-L1 Positivity in Homologous Recombination Deficient Pancreatic Ductal Adenocarcinoma.Front Oncol2022
35701533Distinct mechanisms of innate and adaptive immune regulation underlie poor oncologic outcomes associated with KRAS-TP53 co-alteration in pancreatic cancer.Oncogene2022
35694787Correction: GATA6 Expression Distinguishes Classical and Basal-like Subtypes in Advanced Pancreatic Cancer.Clin Cancer Res2022
35714671Is Biannual Surveillance for Pancreatic Cancer Sufficient in Individuals With Genetic Syndromes or Familial Pancreatic Cancer?J Natl Compr Canc Netw2022
36209277Integrative analysis of KRAS wildtype metastatic pancreatic ductal adenocarcinoma reveals mutation and expression-based similarities to cholangiocarcinoma.Nat Commun2022
36223343Mitochondrial fitness and cancer risk.PLoS One2022
36222851hENT1 Expression Predicts Response to Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Ductal Adenocarcinoma.Clin Cancer Res2022
32958704Delving into Early-onset Pancreatic Ductal Adenocarcinoma: How Does Age Fit In?Clin Cancer Res2021
33524400Genomic Features and Classification of Homologous Recombination Deficient Pancreatic Ductal Adenocarcinoma.Gastroenterology2021
34644529Spatially confined sub-tumor microenvironments in pancreatic cancer.Cell2021
34294813The value of GATA6 immunohistochemistry and computer-assisted diagnosis to predict clinical outcome in advanced pancreatic cancer.Sci Rep2021
33051307Subtype-Discordant Pancreatic Ductal Adenocarcinoma Tumors Show Intermediate Clinical and Molecular Characteristics.Clin Cancer Res2021
33151087Validation of Prognostic Radiomic Features From Resectable Pancreatic Ductal Adenocarcinoma in Patients With Advanced Disease Undergoing Chemotherapy.Can Assoc Radiol J2021
32156747GATA6 Expression Distinguishes Classical and Basal-like Subtypes in Advanced Pancreatic Cancer.Clin Cancer Res2020
31964786A Four-Chemokine Signature Is Associated with a T-cell-Inflamed Phenotype in Primary and Metastatic Pancreatic Cancer.Clin Cancer Res2020
31932696Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution.Nat Genet2020
32051610Author Correction: Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution.Nat Genet2020
32816949A Preclinical Trial and Molecularly Annotated Patient Cohort Identify Predictive Biomarkers in Homologous Recombination-deficient Pancreatic Cancer.Clin Cancer Res2020
30686769Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in Metastases.Cancer Cell2019
30629588Whole genomes define concordance of matched primary, xenograft, and organoid models of pancreas cancer.PLoS Comput Biol2019
29288237Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS Trial.Clin Cancer Res2018
29853643Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer.Cancer Discov2018
29378198Mutations in Mitochondrial DNA From Pancreatic Ductal Adenocarcinomas Associate With Survival Times of Patients and Accumulate as Tumors Progress.Gastroenterology2018
29396858Recapitulating the clinical scenario of BRCA-associated pancreatic cancer in pre-clinical models.Int J Cancer2018
29074453Exome-Wide Association Study of Pancreatic Cancer Risk.Gastroenterology2018
27768182Association of Distinct Mutational Signatures With Correlates of Increased Immune Activity in Pancreatic Ductal Adenocarcinoma.JAMA Oncol2017
28489577Pancreatic cancer ascites xenograft-an expeditious model mirroring advanced therapeutic resistant disease.Oncotarget2017
27851734Erratum: A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns.Nature2017
27732578A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns.Nature2016
  • 1 - 35 of 35

Recommended Authors

Walid K Chatila
Memorial Sloan Kettering Cancer Center
Career Start Year 2017
Number of shared co-authors 0
Sebastian Uhrig
National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ)
Career Start Year 2016
Number of shared co-authors 1
Ritika Kundra
Memorial Sloan Kettering Cancer Center
Career Start Year 2016
Number of shared co-authors 0
Reyka G Jayasinghe
Washington University in St Louis
Career Start Year 2015
Number of shared co-authors 3
Sahil Seth
The University of Texas MD Anderson Cancer Center
Career Start Year 2014
Number of shared co-authors 12
Joshua Armenia
Oncology R&D
Career Start Year 2013
Number of shared co-authors 0
Arshi Arora
Memorial Sloan Kettering Cancer Center
Career Start Year 2011
Number of shared co-authors 0
Edik M Blais
University of Virginia
Career Start Year 2010
Number of shared co-authors 0
Jeran K Stratford
Research Triangle Institute (RTI)
Career Start Year 2009
Number of shared co-authors 0
Amber L Johns
Garvan Institute of Medical Research and The Kinghorn Cancer Centre
Career Start Year 2009
Number of shared co-authors 15
Eliezer M Van Allen
Dana-Farber Cancer Institute
Career Start Year 2009
Number of shared co-authors 4
Charlotte K Y Ng
University of Bern
Career Start Year 2009
Number of shared co-authors 7
Salvatore Piscuoglio
University of Basel
Career Start Year 2008
Number of shared co-authors 7
Nicola Waddell
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 21
Barry S Taylor
Memorial Sloan Kettering Cancer Center
Career Start Year 2006
Number of shared co-authors 3
John Paul Shen
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 2
Albrecht Stenzinger
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 1
Florencia McAllister
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 2
Lakshmi Muthuswamy
Harvard Medical School
Career Start Year 2005
Number of shared co-authors 24
Katherine A Hoadley
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Career Start Year 2004
Number of shared co-authors 13
Olivier Harismendy
University of California
Career Start Year 2003
Number of shared co-authors 3
Jianhua Zhang
University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 4
Peter Horak
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Career Start Year 2003
Number of shared co-authors 1
Nikolaus Schultz
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 5
Umesh Bhanot
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 1
Eric A Collisson
University of California san francisco
Career Start Year 1999
Number of shared co-authors 2
Charles Swanton
Francis Crick Institute
Career Start Year 1997
Number of shared co-authors 10
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 10
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1996
Number of shared co-authors 0
Anirban Maitra
The University of Texas MD Anderson Cancer Center
Career Start Year 1993
Number of shared co-authors 19

Collaborators

Steven Gallinger
Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto
Co-authored papers 34
Robert E Denroche
Ontario Institute for Cancer Research
Co-authored papers 28
Gun Ho Jang
Ontario Institute for Cancer Research
Co-authored papers 26
Faiyaz Notta
2Ontario Institute for Cancer Research
Co-authored papers 24
John M S Bartlett
University of Edinburgh
Co-authored papers 14
Dianne Chadwick
University Health Network
Co-authored papers 10
Ashton A Connor
Houston Methodist Hospital
Co-authored papers 10
Lincoln Stein
Ontario Institute for Cancer Research, University Avenue
Co-authored papers 7
Steven J M Jones
University of British Columbia
Co-authored papers 6
Rama Khokha
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 6
Paul M Krzyzanowski
Ontario Institute for Cancer Research
Co-authored papers 6
Janessa Laskin
Co-authored papers 6
Michelle Chan-Seng-Yue
Princess Margaret Cancer Centre
Co-authored papers 6
Mathieu Lemire
The Hospital for Sick Children
Co-authored papers 6
Marco A Marra
University of British Columbia
Co-authored papers 6
Mehdi Masoomian
University Health Network
Co-authored papers 4
David W Hedley
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 4
Gloria M Petersen
Mayo Clinic
Co-authored papers 4
Lee Timms
Ontario Institute for Cancer Research, University Avenue
Co-authored papers 4
Peter J Campbell
Wellcome Sanger Institute
Co-authored papers 4
Ludmil B Alexandrov
Moores Cancer Center, university of california san diego
Co-authored papers 3
Danielle Pasternack
Nicklaus Children's Hospital
Co-authored papers 3
Richard A Moore
Co-authored papers 3
William D Foulkes
Segal Cancer Centre, Jewish General Hospital
Co-authored papers 3
Benjamin Haibe-Kains
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 3
Ming-Sound Tsao
University Health Network, University of Toronto
Co-authored papers 3
Jessica K Miller
Ontario Institute for Cancer Research, University Avenue
Co-authored papers 3
John D McPherson
Ontario Institute for Cancer Research
Co-authored papers 3
Oliver F Bathe
Cumming School of Medicine, University of Calgary
Co-authored papers 3
Steve E Kalloger
University of British Columbia
Co-authored papers 3
Release 1.2